Author: CSN
Mike Tyson and Ric Flair File $50 Million Federal Lawsuit Against Their Former Cannabis Business Partners
Mike Tyson and Ric Flair File $50 Million Federal Lawsuit Against Their Former Cannabis Business Partners Mike Tyson Ric Flair…
Cannabis reclassification could finally end the industry’s financial exile
President Donald Trump’s executive order to fast-track the reclassification of cannabis offers hope to a $30 billion industry that is…
Mike Tyson and Ric Flair file $50M lawsuit against ex-cannabis business partners
Mike Tyson and Ric Flair have joined forces to file a $50 million lawsuit against their former cannabis business partners.
Mike Tyson Sues Former Cannabis Business Partners For $50M
Mike Tyson and Ric Flair, have filed a lawsuit against former executives for alleged fraud, breach of contract, and other claims.
This Stock Has Almost Tripled in 6 Months. Here’s What Investors Need to Watch Next
Now, it’s worth noting Stock Advisor’s total average return is 975 % — a market-crushing outperformance compared to 193% for…
Trump’s marijuana order throws lifeline to hemp industry
President Trump threw the hemp industry a lifeline with his order to speed up marijuana rescheduling and launch Medicare coverage…
Cannabis retailers celebrate potential reclassification from Schedule 1 to Schedule 3
Cannabis retailers celebrate Trump’s executive order to reclassify marijuana from Schedule 1 to 3, potentially reducing taxes from 70% to…
Mike Tyson and WWE legend Ric Flair sue ex-cannabis business partners for $50 million amid alleged financial misconduct
Mike Tyson and Ric Flair have submitted a lawsuit seeking $50 million in damages and legal fees related to their…
Trump Rejected ‘Half-Assed’ Plan To Move Marijuana To Schedule II During ‘Insane’ Oval Office Meeting, ScottsMiracle-Grow CEO Says
The head of the major gardening supply company Scotts Miracle-Gro says President Donald Trump called a proposal to move marijuana…
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
Gregory D. Gorgas, Chief Executive Officer of Artelo, added, “ART12.11 was purpose-built to meet the standards required for federal healthcare…
Recent Comments